"We'd rather participate in the rather dramatic growth, rather than just watching it happen and essentially being disrupted ...
Illumina, Inc. (NASDAQ: ILMN) and MyOme, a leading genomics innovation and risk modeling company, today announced a collaboration and investment by Illumina into MyOme. The collaboration and investmen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results